Title : Efficacy of olmesartan therapy on fibrinolytic capacity in patients with hypertension.

Pub. Date : 2011 Jan

PMID : 20975532






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Therefore, the aim of the present study was to investigate the efficacy of olmesartan on hemostatic/fibrinolytic status by measuring plasma level of plasminogen activator inhibitor-1 (PAI-1) and soluble thrombomodulin levels in patients with hypertension. olmesartan thrombomodulin Homo sapiens
2 Olmesartan medoxomil decreased plasma PAI-1 and thrombomodulin levels after 6 months of therapy, indicating a favorable effect on fibrinolytic capacity in patients with essential hypertension. olmesartan thrombomodulin Homo sapiens